---
title: "APLMW.US (APLMW.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/APLMW.US/news.md"
symbol: "APLMW.US"
name: "APLMW.US"
parent: "https://longbridge.com/zh-CN/quote/APLMW.US.md"
datetime: "2026-03-16T06:39:11.179Z"
locales:
  - [en](https://longbridge.com/en/quote/APLMW.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/APLMW.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/APLMW.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/APLMW.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/APLMW.US/news.md)


# APLMW.US (APLMW.US) — 相关新闻

### [New drug approval brings hope; experts say the research and development of fatty liver treatment is far from over](https://longbridge.com/zh-CN/news/279190976.md)
*2026-03-16T02:22:17.000Z*
> The approval of new drugs brings hope for the treatment of fatty liver, but experts point out that diabetes treatment st

### [China Post Securities: Vitamins have started to enter a price increase channel, and there may be significant upward potential in the future](https://longbridge.com/zh-CN/news/279161870.md)
*2026-03-15T15:00:28.000Z*
> China Postal Securities pointed out that the prices of vitamin raw materials were at historically low levels before the 

### [Health care roundup: Market talk](https://longbridge.com/zh-CN/news/279095255.md)
*2026-03-13T21:31:16.000Z*
> Find insight on EssilorLuxottica, the pharmaceutical industry and more in the latest Market Talks covering the Health Ca

### [WHO directs antibiotic development to priority pathogens](https://longbridge.com/zh-CN/news/279045396.md)
*2026-03-13T11:36:33.000Z*
> The World Health Organization (WHO) has published Target Product Profiles (TPPs) for three priority infections to guide 

### [Global Advances in Medicine Shape Future Developments](https://longbridge.com/zh-CN/news/278946179.md)
*2026-03-12T21:09:43.000Z*
> Recent global breakthroughs in medicine are shaping future healthcare outcomes. Bloomberg highlights the significance of

### [Health Rounds: Eliquis proves safer than Xarelto for patients with deep blood clots](https://longbridge.com/zh-CN/news/278932385.md)
*2026-03-12T19:26:03.000Z*
### [Hepatology: New strategies for enhancing efficacy and reducing toxicity! A team led by Ye Linsen from Sun Yat-sen University discovered that low-dose gemcitabine/cisplatin can reshape the immune microenvironment and enhance the efficacy of PD-L1 inhibitors](https://longbridge.com/zh-CN/news/278818998.md)
*2026-03-12T04:30:37.000Z*
> The research team at Sun Yat-sen University found that low-dose gemcitabine/cisplatin (LDGC) combined with anti-PD-L1 an

### [Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook](https://longbridge.com/zh-CN/news/278774326.md)
*2026-03-11T20:11:40.000Z*
> Phase 1 of the clinical trial FHD-909 (LY4050784) is progressing according to schedule, with a primary focus on SMARCA4 

### [New treatment plan for AIDS! Lancet: A new once-daily oral tablet is expected to replace the complex multi-tablet regimen](https://longbridge.com/zh-CN/news/278650604.md)
*2026-03-11T03:25:21.000Z*
> According to the results of three clinical trials published in The Lancet, a new once-daily oral HIV treatment pill, com